Experts Available

Add to Favorites Subscribe Share
newswise-fb-share-

Showing results

15 of 5
HFHSLogo.jpg

Article ID: 714507

Henry Ford Cancer Institute Treats its First Patient with Innovative ‘Living Drug’ Therapy

Henry Ford Health System

Henry Ford Cancer Institute has treated its first patient with CAR T-cell therapy, an approach that uses engineered cells from a patient's immune system to destroy cancer. The altered cells remain active for years after the treatment, acting as a 'living drug' Only specially-certified trained hospitals can offer CAR T-cell therapy to patients with B-cell acute lymphocytic leukemia (ALL) and diffuse large B-cell lymphoma (DLBCL).

Released:
18-Jun-2019 7:05 AM EDT
Newswise: Michigan’s First Patient Treated with Thalamic Deep Brain Stimulation for Epilepsy at Henry Ford Health System

Article ID: 708858

Michigan’s First Patient Treated with Thalamic Deep Brain Stimulation for Epilepsy at Henry Ford Health System

Henry Ford Health System

Neurosurgeon Jason Schwalb, M.D., with help from the team at the Henry Ford Comprehensive Epilepsy Center, implanted the first complete Deep Brain Stimulation system in Michigan for the treatment of Epilepsy.

Released:
28-Feb-2019 10:05 AM EST
HFHSLogo.jpg

Article ID: 707970

Minimally-Invasive Treatment Option for Early Stage Oral Cancer Reduces Recovery Time, Improves Survival

Henry Ford Health System

Henry Ford Cancer Institute oral cancer patient Marlene Calverley, a minimally-invasive sentinel node biopsy meant having three instead of 30-60 lymph nodes removed, and a two-inch scar instead of a five-to-six-inch scar. It also meant no neck drains, no physical therapy, and a decreased risk of complications.

Released:
12-Feb-2019 12:05 PM EST
Newswise: Innovative Ice-Free Scalp Cooling During Chemotherapy Prevents, Reduces Hair Loss for Breast Cancer Patients

Article ID: 707180

Innovative Ice-Free Scalp Cooling During Chemotherapy Prevents, Reduces Hair Loss for Breast Cancer Patients

Henry Ford Health System

Breast cancer patient Laura Carey returned to work one week after beginning chemotherapy, but without a demoralizing side-effect indicative of this type of cancer treatment – hair loss. Carey is among the first breast cancer patients at the Henry Ford Cancer Institute to successfully prevent and reduce hair loss during chemotherapy by using an ice-free cooling cap system, called Paxman. Dr. Haythem Ali explains more about this innovative treatment option, and what it means for breast cancer patients like Laura.

Released:
29-Jan-2019 9:40 AM EST
Newswise: Few Doctors Have Adequate Training to Effectively Treat Chronic Pain Patients

Article ID: 606430

Few Doctors Have Adequate Training to Effectively Treat Chronic Pain Patients

Henry Ford Health System

Pain is the most common reason a patient sees a physician but few physicians have received adequate training to help their patients, according to a Henry Ford Hospital article published in the Journal of American Osteopathic Association. An estimated 100 million people in the United States are living with chronic pain, which accounts for up to $635 billion annually in health care costs and lost productivity. A 2011 study found that for every medical specialist, there are more than 28,500 patients with chronic pain.

Released:
12-Aug-2013 12:00 PM EDT

Feature Expert

Channels:

Pain, All Journal News,


Showing results

15 of 5

Chat now!